Edition:
United Kingdom

Assertio Therapeutics Inc (ASRT.OQ)

ASRT.OQ on NASDAQ Stock Exchange Global Select Market

4.05USD
14 Dec 2018
Change (% chg)

$-0.15 (-3.57%)
Prev Close
$4.20
Open
$4.16
Day's High
$4.19
Day's Low
$3.99
Volume
240,126
Avg. Vol
204,303
52-wk High
$9.48
52-wk Low
$3.99

Chart for

About

Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution),... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $369.12
Shares Outstanding(Mil.): 62.99
Dividend: --
Yield (%): --

Financials

  ASRT.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -1.79 -- --
ROI: -12.06 15.55 14.96
ROE: -43.53 16.92 16.52

Earnings vs. Estimates